Clinical-grade whole-genome sequencing and 3′ transcriptome analysis of colorectal cancer patients

[1]  A. Broeks,et al.  Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers , 2020, Nature Medicine.

[2]  S. Mirarab,et al.  Sequence Analysis , 2020, Encyclopedia of Bioinformatics and Computational Biology.

[3]  Steven J. M. Jones,et al.  Pan-cancer analysis of whole genomes , 2020, Nature.

[4]  Charles M. Perou,et al.  Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: comparison of gene expression profiling approaches , 2020, BMC Bioinformatics.

[5]  M. Wing,et al.  Tumor heterogeneity and acquired drug resistance in FGFR2-fusion-positive cholangiocarcinoma through rapid research autopsy , 2019, Cold Spring Harbor molecular case studies.

[6]  William A. Pastor,et al.  SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer , 2019, Nature Communications.

[7]  Jules N. A. Kerssemakers,et al.  Whole genome sequencing puts forward hypotheses on metastasis evolution and therapy in colorectal cancer , 2018, Nature Communications.

[8]  T A Chan,et al.  Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  E. Chan,et al.  Whole-Genome Sequencing Reveals Elevated Tumor Mutational Burden and Initiating Driver Mutations in African Men with Treatment-Naïve, High-Risk Prostate Cancer. , 2018, Cancer research.

[10]  R. Collins,et al.  Durable Remissions with Ivosidenib in IDH1‐Mutated Relapsed or Refractory AML , 2018, The New England journal of medicine.

[11]  Ville Mustonen,et al.  The repertoire of mutational signatures in human cancer , 2018, Nature.

[12]  The 100 000 Genomes Project: bringing whole genome sequencing to the NHS , 2018, British Medical Journal.

[13]  D. Smedley,et al.  The 100 000 Genomes Project: bringing whole genome sequencing to the NHS , 2018, British Medical Journal.

[14]  H. Nakagawa,et al.  Whole genome sequencing analysis for cancer genomics and precision medicine , 2018, Cancer science.

[15]  A. Abyzov,et al.  Molecular characterization of colorectal adenomas with and without malignancy reveals distinguishing genome, transcriptome and methylome alterations , 2018, Scientific Reports.

[16]  Clare Verrill,et al.  Clinical whole-genome sequencing from routine formalin-fixed, paraffin-embedded specimens: pilot study for the 100,000 Genomes Project , 2018, Genetics in Medicine.

[17]  Michelle D. Wang,et al.  Mfd Dynamically Regulates Transcription via a Release and Catch-Up Mechanism , 2018, Cell.

[18]  J. Kocher,et al.  Early genetic aberrations in patients with sporadic colorectal cancer , 2018, Molecular carcinogenesis.

[19]  R. Lothe,et al.  CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models , 2017, Scientific Reports.

[20]  Alex H. Wagner,et al.  DGIdb 3.0: a redesign and expansion of the drug–gene interaction database , 2017, bioRxiv.

[21]  P. Raman,et al.  Overcoming resistance to single-agent therapy for oncogenic BRAF gene fusions via combinatorial targeting of MAPK and PI3K/mTOR signaling pathways , 2017, Oncotarget.

[22]  P. Stephens,et al.  Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers , 2017, Molecular Cancer Therapeutics.

[23]  I. Kralj-Hans,et al.  Adenoma surveillance and colorectal cancer incidence: a retrospective, multicentre, cohort study , 2017, The Lancet. Oncology.

[24]  Elisa Ficarra,et al.  Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer , 2017, Nature Communications.

[25]  Andy G Lynch,et al.  Telomerecat: A ploidy-agnostic method for estimating telomere length from whole genome sequencing data , 2017, Scientific Reports.

[26]  M. Stratton,et al.  Universal Patterns of Selection in Cancer and Somatic Tissues , 2017, Cell.

[27]  M. Gerstein,et al.  Using FunSeq2 for Coding and Non‐Coding Variant Annotation and Prioritization , 2017, Current protocols in bioinformatics.

[28]  Gautier Koscielny,et al.  Open Targets: a platform for therapeutic target identification and validation , 2016, Nucleic Acids Res..

[29]  G. Gastl,et al.  Targeted Therapy of Colorectal Cancer , 2016, Oncology Research and Treatment.

[30]  J. Marcickiewicz,et al.  Lowered Expression of Tumor Suppressor Candidate MYO1C Stimulates Cell Proliferation, Suppresses Cell Adhesion and Activates AKT , 2016, PloS one.

[31]  Edwin Cuppen,et al.  MutationalPatterns: comprehensive genome-wide analysis of mutational processes , 2016, Genome Medicine.

[32]  Angie Duy Vo,et al.  Identifying fusion transcripts using next generation sequencing , 2016, Wiley interdisciplinary reviews. RNA.

[33]  R. Dzijak,et al.  Nuclear myosin I regulates cell membrane tension , 2016, Scientific Reports.

[34]  S. Leedham,et al.  Wnt disruption in colorectal polyps – the traditional serrated adenoma enters the fray , 2016, The Journal of pathology.

[35]  A. Abyzov,et al.  Colorectal Cancer with Residual Polyp of Origin: A Model of Malignant Transformation12 , 2016, Translational oncology.

[36]  Philippe Rinaudo,et al.  biosigner: A New Method for the Discovery of Significant Molecular Signatures from Omics Data , 2016, Front. Mol. Biosci..

[37]  M. Salto‐Tellez,et al.  Challenging the Cancer Molecular Stratification Dogma: Intratumoral Heterogeneity Undermines Consensus Molecular Subtypes and Potential Diagnostic Value in Colorectal Cancer , 2016, Clinical Cancer Research.

[38]  Hedi Peterson,et al.  g:Profiler—a web server for functional interpretation of gene lists (2016 update) , 2016, Nucleic Acids Res..

[39]  Xiaoyu Chen,et al.  Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications , 2016, Bioinform..

[40]  Eric S. Lander,et al.  Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma , 2016, Cell reports.

[41]  Steve Lee,et al.  Canvas: versatile and scalable detection of copy number variants , 2016, bioRxiv.

[42]  James Y. Dai,et al.  Copy number alterations detected by whole-exome and whole-genome sequencing of esophageal adenocarcinoma , 2015, Human Genomics.

[43]  Jeffrey S. Morris,et al.  The Consensus Molecular Subtypes of Colorectal Cancer , 2015, Nature Medicine.

[44]  E. Samuelson,et al.  Analysis of an independent tumor suppressor locus telomeric to Tp53 suggested Inpp5k and Myo1c as novel tumor suppressor gene candidates in this region , 2015, BMC Genetics.

[45]  H. Kempski,et al.  PAX5 alterations in genetically unclassified childhood Precursor B‐cell acute lymphoblastic leukaemia , 2015, British journal of haematology.

[46]  A. Magi,et al.  Detection of Genomic Structural Variants from Next-Generation Sequencing Data , 2015, Front. Bioeng. Biotechnol..

[47]  Yali Dou,et al.  Hijacked in cancer: the KMT2 (MLL) family of methyltransferases , 2015, Nature Reviews Cancer.

[48]  T. Rőszer,et al.  Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms , 2015, Mediators of inflammation.

[49]  A. Ryan,et al.  ATM and ATR as therapeutic targets in cancer. , 2015, Pharmacology & therapeutics.

[50]  J. Ji,et al.  Oncogenic HER2 fusions in gastric cancer , 2015, Journal of Translational Medicine.

[51]  A. Beggs,et al.  An immunogenomic stratification of colorectal cancer: Implications for development of targeted immunotherapy , 2015, Oncoimmunology.

[52]  J. Casanova,et al.  Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants , 2014, Proceedings of the National Academy of Sciences.

[53]  M. Gerstein,et al.  FunSeq2: a framework for prioritizing noncoding regulatory variants in cancer , 2014, Genome Biology.

[54]  Nicole A. Lavender,et al.  Whole genome sequencing reveals potential targets for therapy in patients with refractory KRAS mutated metastatic colorectal cancer , 2014, BMC Medical Genomics.

[55]  Lawrence C. LaPointe,et al.  A panel of genes methylated with high frequency in colorectal cancer , 2014, BMC Cancer.

[56]  Benjamin J. Raphael,et al.  Mutational landscape and significance across 12 major cancer types , 2013, Nature.

[57]  Michael P. Schroeder,et al.  IntOGen-mutations identifies cancer drivers across tumor types , 2013, Nature Methods.

[58]  Semyon Kruglyak,et al.  Isaac: ultra-fast whole-genome secondary analysis on Illumina sequencing platforms , 2013, Bioinform..

[59]  Vicent Pelechano,et al.  An efficient method for genome-wide polyadenylation site mapping and RNA quantification , 2013, Nucleic acids research.

[60]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.

[61]  A. Børresen-Dale,et al.  Mutational Processes Molding the Genomes of 21 Breast Cancers , 2012, Cell.

[62]  Wendy S. W. Wong,et al.  Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs , 2012, Bioinform..

[63]  Giovanni Parmigiani,et al.  Integrating diverse genomic data using gene sets , 2011, Genome Biology.

[64]  A. Toker,et al.  NFAT proteins: emerging roles in cancer progression , 2009, Nature Reviews Cancer.

[65]  J. Marshall,et al.  Targeted therapy for colorectal cancer. , 2006, Current opinion in investigational drugs.

[66]  L. Ellis,et al.  Chronic Oxaliplatin Resistance Induces Epithelial-to-Mesenchymal Transition in Colorectal Cancer Cell Lines , 2006, Clinical Cancer Research.

[67]  A. Marx,et al.  Efficacy and safety of imatinib in adult patients with c-kit-positive acute myeloid leukemia. , 2004, Blood.

[68]  J. L. Petersen,et al.  REX1, a Novel Gene Required for DNA Repair* , 2003, Journal of Biological Chemistry.

[69]  Hans Clevers,et al.  Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC , 1997, Science.

[70]  Ash A. Alizadeh,et al.  Profiling Tumor Infiltrating Immune Cells with CIBERSORT. , 2018, Methods in molecular biology.

[71]  Trevor J Pugh,et al.  Mutational heterogeneity in cancer and the search for new cancer genes , 2014 .

[72]  Trevor J Pugh,et al.  Mutational heterogeneity in cancer and the search for new cancer genes , 2014 .